GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Terns Pharmaceuticals Inc (STU:430) » Definitions » Short Interest

Terns Pharmaceuticals (STU:430) Short Interest


View and export this data going back to 2021. Start your Free Trial

What is Terns Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Terns Pharmaceuticals's Short Interest

For the Biotechnology subindustry, Terns Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terns Pharmaceuticals's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Terns Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Terns Pharmaceuticals's Short Interest falls into.


;
;

Terns Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Terns Pharmaceuticals Inc (STU:430) » Definitions » Short Interest
Comparable Companies
ALMS PVLA TSVT CRVS OCGN INZY CADL TVRD VNDA GOSS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TERN:USA 430:Germany
Address
1065 East Hillsdale Boulevard, Suite 100, Foster, CA, USA, 94404
Website
https://www.ternspharma.com
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Terns Pharmaceuticals Headlines

No Headlines